-+ 0.00%
-+ 0.00%
-+ 0.00%
Parker Waichman Client Shares Story of GLP-1-Related Vision Loss with FOX Boston 25 News
Share
Listen to the news

FOX Boston 25 News Report Features Georgia Client and Highlights Parker Waichman Lawsuit Filed on Behalf of Massachusetts GLP 1 NAION Patient

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Parker Waichman LLP announced today that a firm client who suffered permanent vision loss after using a GLP-1 medication was featured in a FOX Boston 25 News report examining the potential association between popular GLP-1 drugs and non-arteritic anterior ischemic optic neuropathy ("NAION"). The report also highlighted a lawsuit filed by Parker Waichman on behalf of a Massachusetts client who alleges that he developed NAION after using Wegovy.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending